Antimicrobial Irrigation System Improves Wound Lavage
By HospiMedica International staff writers Posted on 30 Jun 2021 |
Image: The Irrisept 450 bottle with the Irriprobe (Photo courtesy of Irrimax)
A self-contained irrigation system provides low pressure lavage to mechanically cleanse the wound and remove microorganisms.
The Irrimax (Lawrenceville, GA, USA) Irrisept lavage system is based on a unique 450 ml bottle design that allows users to control delivery pressure of the irrigation solution through manual bottle compression. By grasping the bottle firmly, the user can control the direction and pressure of the proprietary Irriprobe applicator to help remove particulate and debris by mechanical action. The bottle contains low concentration (0.05%) chlorhexidine gluconate (CHG) in sterile water that acts as a preservative to inhibit microbial growth.
The entire system is provided in a sterile, single use, single patient packaging. Following wound lavage, further rinsing with normal saline is recommended after one minute. The action of the Irrisept preservative has shown demonstrated effectiveness against the growth of a variety of both gram-positive and gram-negative bacteria, fungi, and viruses. It has also successfully completed testing for cytotoxicity, skin irritation, and sensitization/immune allergic response.
“Irrisept offers ease of use with a packaging configuration that is sterile, easy to open and ready to use; there is no mixing, dispensing, or attachment to an additional irrigation,” said Mark Alvarez, CEO of Irrimax. “Looking ahead, our goal for Irrisept remains to become the standard of care in the United States and across the globe.”
CHG is a cationic bisbiguanide salt that works by destroying the bacterial cell membrane and precipitating cell contents. The attraction of the positively charged CHG molecule to negatively charged bacterial cell wall causes disruption of the cell membrane and subsequent cellular death.
Related Links:
Irrimax
The Irrimax (Lawrenceville, GA, USA) Irrisept lavage system is based on a unique 450 ml bottle design that allows users to control delivery pressure of the irrigation solution through manual bottle compression. By grasping the bottle firmly, the user can control the direction and pressure of the proprietary Irriprobe applicator to help remove particulate and debris by mechanical action. The bottle contains low concentration (0.05%) chlorhexidine gluconate (CHG) in sterile water that acts as a preservative to inhibit microbial growth.
The entire system is provided in a sterile, single use, single patient packaging. Following wound lavage, further rinsing with normal saline is recommended after one minute. The action of the Irrisept preservative has shown demonstrated effectiveness against the growth of a variety of both gram-positive and gram-negative bacteria, fungi, and viruses. It has also successfully completed testing for cytotoxicity, skin irritation, and sensitization/immune allergic response.
“Irrisept offers ease of use with a packaging configuration that is sterile, easy to open and ready to use; there is no mixing, dispensing, or attachment to an additional irrigation,” said Mark Alvarez, CEO of Irrimax. “Looking ahead, our goal for Irrisept remains to become the standard of care in the United States and across the globe.”
CHG is a cationic bisbiguanide salt that works by destroying the bacterial cell membrane and precipitating cell contents. The attraction of the positively charged CHG molecule to negatively charged bacterial cell wall causes disruption of the cell membrane and subsequent cellular death.
Related Links:
Irrimax
Latest Critical Care News
- AI to Improved Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia